Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III Multicenter Study in Epithelial Ovarian Carcinoma FIGO Stage IIB-IV Comparing Treatment With Paclitaxel and Carboplatin to Paclitaxel and Carboplatin Sequentially Followed by Topotecan

NCT00102375 is registered in ClinicalTrials.gov with AGO Study Group as lead sponsor.

NCT NCT00102375
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00102375 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III Multicenter Study in Epithelial Ovarian Carcinoma FIGO Stage IIB-IV Comparing Treatment With Paclitaxel and Carboplatin to Paclitaxel and Carboplatin Sequentially Followed by Topotecan
Lead sponsor
AGO Study Group
Phase
Phase 3
Overall status
Completed
Start date
December 31, 1999
Completion date
October 31, 2004
Enrollment
900
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

ovarian cancer